The trademark application BEXCOVEV was filed by Regeneron Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on September 30, 2020, and it was registered by office on January 8, 2021 without any oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 5 with Pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders and antivirals for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders..